Highlights Bayer AG

Equities

Delayed Xetra Other stock markets 11:40:23 2024-04-30 am EDT			5-day change	1st Jan Change
27.35 ^EUR	-0.87%		+0.13%	-18.67%

Apr. 30	Bayer: strategic collaboration with Evotec	CF
Apr. 30	Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies	MT

Bayer: strategic collaboration with Evotec	Apr. 30	CF
Evotec, Bayer to Collaborate on New Cardiovascular Disease Therapies	Apr. 30	MT
Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	Apr. 30	MT
Bayer and Evotec Collaborate to Advance Precision Cardiology	Apr. 30	CI
J&J, Bristol Myers lose challenges to US drug price negotiation program	Apr. 29	RE
Bayer: positive results with Eylea in ophthalmology	Apr. 29	CF
Roche Holding AG: slimming down	Apr. 29
Habeck's 'pharma trip' - industry sees structural problems	Apr. 29	DP
Ex-dividend day for final dividend	Apr. 28	FA
Bayer CEO wins first AGM shareholder vote	Apr. 26	RE
BAYER SAYS INVESTORS WITH 91.69% OF EQUITY CAPITAL REPRESENTED A…	Apr. 26	RE
Bayer: CEO's positive AGM speech welcomed	Apr. 26	CF
Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15	Apr. 25	DP
Bayer, AlphaBio Control Sign Exclusive License Deal for Biological Insecticide	Apr. 23	MT
Bayer Signs Renewable Energy Purchase Deal for Six German Sites	Apr. 19	MT
Bayer: signs renewable energy supply contract	Apr. 19	CF
Capgemini: new platform implemented for Bayer	Apr. 19	CF
Bayer’s Investigational Gene Therapy for Heart Failure Gets US FDA Fast Track Designation	Apr. 18	MT
AskBio receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure	Apr. 18	CI
Study: US companies outpace Europe and Asia in research spending	Apr. 18	DP

No results for this search

BAYER : Another peer group tidy up

April 14, 2024 at 03:26 pm EDT

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am EST